Cipla’s Global Chief Scientific Officer Pradeep Bhadauria resigns | Business Upturn

Top Stories

Government increases LPG allocation for industries to 70% of pre-crisis levels; Petroleum Secretary writes to states Iran Rejects US Proposal and Calls Talks a Third Deception — And Now Sirens Are Sounding in Northern Israel Iran Has Responded to the US 15-Point Proposal — Here Are Tehran’s Conditions and Why It Called the Talks a Deception Trump slams NATO for “doing nothing” on Iran, says US needs nothing from allies Viral Video: Internet divided over Priyanka Chopra’s ‘awkward’ interaction with Anne Hathaway and Dua Lipa at Bvlgari Event Iran demands recognition of sovereignty over Strait of Hormuz as ‘legal right’ Setback for Dr Reddy’s as Delhi High Court asks company to halt Olympiq drug sales 11 Airlines Dead in 10 Years — Why India Is One of the Hardest Countries in the World to Run an Airline Government increases LPG allocation for industries to 70% of pre-crisis levels; Petroleum Secretary writes to states Iran Rejects US Proposal and Calls Talks a Third Deception — And Now Sirens Are Sounding in Northern Israel Iran Has Responded to the US 15-Point Proposal — Here Are Tehran’s Conditions and Why It Called the Talks a Deception Trump slams NATO for “doing nothing” on Iran, says US needs nothing from allies Viral Video: Internet divided over Priyanka Chopra’s ‘awkward’ interaction with Anne Hathaway and Dua Lipa at Bvlgari Event Iran demands recognition of sovereignty over Strait of Hormuz as ‘legal right’ Setback for Dr Reddy’s as Delhi High Court asks company to halt Olympiq drug sales 11 Airlines Dead in 10 Years — Why India Is One of the Hardest Countries in the World to Run an Airline

Cipla has announced the resignation of Mr Pradeep Bhadauria, the Global Chief Scientific Officer and a member of the Management Council. Bhadauria, who is also an employee of Cipla USA Inc., a wholly owned subsidiary of the company, will be leaving to pursue interests outside Cipla. His last working day is scheduled for 31st March, 2026.

This development marks a significant change in the leadership team of Cipla, as Bhadauria played a crucial role in the company’s scientific and research initiatives. The company has not yet announced a successor for the position.

Cipla, a major player in the pharmaceutical industry, continues to focus on its strategic objectives and growth plans despite this leadership transition. The company has assured stakeholders that it remains committed to its mission of providing affordable healthcare solutions globally.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).

Add us as preferred source on Google

TOPICS: Cipla Cipla USA Inc. Pradeep Bhadauria